Tianan Financial Statements From 2010 to 2024
| TNPH Stock | USD 0.01 0.00 0.00% |
Check Tianan Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tianan Pharmaceutical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Tianan financial statements analysis is a perfect complement when working with Tianan Pharmaceutical Valuation or Volatility modules.
Tianan |
Tianan Pharmaceutical Co Company Return On Equity Analysis
Tianan Pharmaceutical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Tianan Pharmaceutical Return On Equity | 0.25 |
Most of Tianan Pharmaceutical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tianan Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Tianan Pharmaceutical Co has a Return On Equity of 0.2512. This is 101.05% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is 181.03% lower than that of the firm.
Tianan Pharmaceutical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Tianan Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Tianan Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tianan Pharmaceutical competition to find correlations between indicators driving Tianan Pharmaceutical's intrinsic value. More Info.Tianan Pharmaceutical Co is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.72 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Tianan Pharmaceutical Co is roughly 1.39 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Tianan Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Tianan Pharmaceutical's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Tianan Pharmaceutical Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Tianan Pharmaceutical income statement, its balance sheet, and the statement of cash flows. Tianan Pharmaceutical investors use historical funamental indicators, such as Tianan Pharmaceutical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Tianan Pharmaceutical investors may use each financial statement separately, they are all related. The changes in Tianan Pharmaceutical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Tianan Pharmaceutical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Tianan Pharmaceutical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Tianan Pharmaceutical. Please read more on our technical analysis and fundamental analysis pages.
Tianan Pharmaceutical Co., Ltd. develops, manufactures, and sells traditional Chinese herbal medicines, including pallets, hard capsules, and soft ointments for the treatment and prevention of diseases in China. The company was founded in 2003 and is based in Xian, China. TianAn Pharm is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| WMT | Walmart | |
| MIDNX | Matthews India Fund | |
| QCOM | Qualcomm Incorporated | |
| SLG | SL Green Realty | |
| MMM | 3M Company |
Other Information on Investing in Tianan Pink Sheet
Tianan Pharmaceutical financial ratios help investors to determine whether Tianan Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tianan with respect to the benefits of owning Tianan Pharmaceutical security.